Privia Health (PRVA)

• Market cap: $2.84B
• 1 day: 0.30%
• 5 days: -0.04%
• 1 month: 4.59%
• 3 months: 4.17%
• 6 months: 25.36%
• Year to date: 19.55%
• 1 year: 27.61%
• 5 years: -32.43%
• 10 years: -32.43%
• Sector: Healthcare
• Industry: Health Information Services

About: Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Employees: 1,140

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

198% more call options, than puts

Call options by funds: $7.97M | Put options by funds: $2.68M

100% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]

60% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 63

8% more capital invested

Capital invested by funds: $2.18B [Q3] → $2.35B (+$169M) [Q4]

0.04% less ownership

Funds ownership: 100.06% [Q3] → 100.03% (-0.04%) [Q4]

2% less funds holding

Funds holding: 232 [Q3] → 228 (-4) [Q4]

10% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 30

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $23 2% downside
• Avg. target: $29 25% upside
• High target: $40 70% upside

9 analyst ratings

• positive: 8 89%
• neutral: 1 11%
• negative: 0 0%

JMP Securities Constantine Davides 40% 1-year accuracy 14 / 35 met price target	24% upside $29	Market Outperform Reiterated	28 Apr 2025
Baird Michael Ha 39% 1-year accuracy 9 / 23 met price target	11% upside $26	Outperform Maintained	15 Apr 2025
Barclays Andrew Mok 36% 1-year accuracy 22 / 61 met price target	2% downside $23	Equal-Weight Maintained	10 Apr 2025
Truist Securities Jailendra Singh 34% 1-year accuracy 12 / 35 met price target	19% upside $28	Buy Maintained	10 Apr 2025
Needham Matthew Sheerin 44% 1-year accuracy 12 / 27 met price target	28% upside $30	Buy Reiterated	10 Apr 2025